Rifaximin Tablet, Coated
NDC Package 62660-150-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Rifaximin tablets is a medication used to treat diarrhea caused by the common bacteria known as E. This formulation utilizes a tablet, coated delivery system. Marketed by Bausch Health Companies Inc., this product is identified by NDC 62660-150.

Identification & Billing

NDC Package Code
62660-150-01
Package Description
32000 TABLET, COATED in 1 DRUM
Product Code
62660-150
11-Digit Billing Format
62660015001

Clinical Specifications

Proprietary Name
Rifaximin
Non-Proprietary Name
Rifaximin
Substance Name
Rifaximin
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Active Ingredient(s)
RIFAXIMIN 550 mg/1
Usage Information
This medication is used to treat diarrhea caused by the common bacteria known as E. coli ("traveler's diarrhea"). Rifaximin should not be used if you have a fever or bloody diarrhea. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Rifaximin is also used to treat irritable bowel syndrome with diarrhea. It is also used to prevent a brain problem caused by liver disease (hepatic encephalopathy). It may help you think more clearly.

Regulatory & Marketing

Labeler Name
Bausch Health Companies Inc.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
05-01-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62660-150-01 identifies a specific commercial package of 32000 tablet, coated in 1 drum of Rifaximin (UNFINISHED drug), drug for further processing labeled by Bausch Health Companies Inc.. This tablet, coated is formulated for use and contains rifaximin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Companies Inc. on May 01, 2010. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat diarrhea caused by the common bacteria known as E. coli ("traveler's diarrhea"). Rifaximin should not be used if you have a fever or bloody diarrhea. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Rifaximin is also used to treat irritable bowel syndrome with diarrhea. It is also used to prevent a brain problem caused by liver disease (hepatic encephalopathy). It may help you think more clearly.

How is this Bausch Health Companies Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62660015001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62660-150-01
11-Digit CMS (5-4-2)
62660-0150-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.